Both in Pharmaceuticals
Zenas BioPharma vs Precigen
Over the past year ZBIO returned −7.9% and PGEN returned +25.0%; their daily moves had a correlation of 0.11.
ZBIO −7.9% PGEN +25.0%Growth of $1, one year, split-adjusted
| Metric | ZBIO | PGEN |
|---|---|---|
| Price | $28.87 | $5.20 |
| Market cap | $1.88B | $1.86B |
| Today | +4.53% | +1.17% |
| 1 month | +3.7% | −32.8% |
| 6 months | +39.1% | +20.1% |
| Year to date | −20.5% | +24.4% |
| 1 year | −7.6% | +25.6% |
| Revenue growth (YoY) | — | +6322.7% |
| Gross margin | 100.0% | 94.9% |
| Net margin | −11145.6% | 36.5% |
| P/E (TTM) | — | — |
| Price / sales | 1,881.7× | 21.7× |
| Net cash | $346.1M | -$55.7M |
| Dividend yield | — | — |
| Volatility (60d) | 56.4% | 86.5% |
| Short % of float | 40.2% | 26.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).